We are live on ! Find out more
ORIA

Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA

Delisted

ORIA was delisted on the 28th of April, 2023.

Back to rankings

48 hedge funds and large institutions have $130M invested in Orion Biotech Opportunities Corp. Class A Ordinary Share in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

20% more funds holding

Funds holding: 40 → 48 (+8)

4% more capital invested

Capital invested by funds: $124M → $130M (+$5.54M)

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

Holders
48
Holders Change
+8
Holders Change %
+20%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
7
Reduced
8
Closed
2
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
+$2K

Top Buyers

Rank Fund Capital Flow
1
HSBC Holdings
HSBC Holdings
United Kingdom
+$6.43M
2
UOC
UBS O'Connor
Illinois
+$2.55M
3
CF
Cantor Fitzgerald
New York
+$1.95M
4
TCA
Taconic Capital Advisors
New York
+$1.9M
5
FTCM
First Trust Capital Management
Illinois
+$1.71M

Top Sellers

Rank Fund Capital Flow
1
LA
Linden Advisors
New York
-$6.43M
2
ACA
Arena Capital Advisors
California
-$2.47M
3
FTCM
Fir Tree Capital Management
New York
-$485K
4
FLC
Fifth Lane Capital
Texas
-$326K
5
EAM
Exos Asset Management
New York
-$92.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
6CM
1
683 Capital Management
New York
$11.7M – – –
FTCM
2
Fir Tree Capital Management
New York
$9.26M -$485K -49,700 -5%
KL
3
KIM LLC
Kansas
$7.79M +$7.81M +800,000 New
MI
4
MMCAP International
Cayman Islands
$7.79M – – –
CF
5
Cantor Fitzgerald
New York
$6.71M +$1.95M +200,000 +41%
HSBC Holdings
6
HSBC Holdings
United Kingdom
$6.41M +$6.43M +658,186 New
CSS
7
Cubist Systematic Strategies
Connecticut
$6.18M -$5.18K -530 -0.1%
PC
8
Periscope Capital
Ontario, Canada
$5.83M – – –
ACM
9
Atalaya Capital Management
New York
$4.87M – – –
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
10
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$4.87M – – –
KC
11
Kepos Capital
New York
$4.87M – – –
PSAMP
12
P. Schoenfeld Asset Management (PSAM)
New York
$4.87M – – –
HighTower Advisors
13
HighTower Advisors
Illinois
$4.75M -$23.4K -2,400 -0.5%
Millennium Management
14
Millennium Management
New York
$4.25M +$500K +51,250 +13%
RCM
15
Radcliffe Capital Management
Pennsylvania
$4.01M +$118K +12,103 +3%
AGC
16
Angelo Gordon & Co
New York
$2.92M – – –
Marshall Wace
17
Marshall Wace
United Kingdom
$2.68M – – –
UOC
18
UBS O'Connor
Illinois
$2.55M +$2.55M +261,488 New
ACA
19
Arena Capital Advisors
California
$2.44M -$2.47M -252,917 -50%
SC
20
Sculptor Capital
New York
$2.43M – – –
SCM
21
Shaolin Capital Management
Florida
$2.16M -$1.95K -200 -0.1%
AA
22
AQR Arbitrage
Connecticut
$1.95M – – –
TCA
23
Taconic Capital Advisors
New York
$1.9M +$1.9M +195,000 New
FTCM
24
First Trust Capital Management
Illinois
$1.7M +$1.71M +175,000 New
WRBC
25
W.R. Berkley Corp
Connecticut
$1.69M – – –
1
2

ORIA Hedge Fund Activity: Q2 2022 in Review

48 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) for Q2 2022, worth a combined $130M — up 4.5% from $124M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new ORIA positions and 2 closed out — a net gain of 8 holders — while 7 added to existing stakes and 8 trimmed.

The largest buyer was HSBC Holdings, opening a new position worth an estimated $6.43M. The largest seller was Linden Advisors, cutting an estimated $6.43M.

  • 48 institutional investors held Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) as of Q2 2022, up from 40 in Q1 2022.
  • Funds reported $130M of Orion Biotech Opportunities Corp. Class A Ordinary Share stock for Q2 2022, up 4.5% quarter-over-quarter.
  • 10 funds opened new Orion Biotech Opportunities Corp. Class A Ordinary Share positions in Q2 2022 and 2 closed out, a net change of +8 holders.
  • The largest Orion Biotech Opportunities Corp. Class A Ordinary Share buyer in Q2 2022 was HSBC Holdings, an estimated $6.43M added.
  • The largest Orion Biotech Opportunities Corp. Class A Ordinary Share seller in Q2 2022 was Linden Advisors, an estimated $6.43M sold.

Based on aggregated 13F filings for Q2 2022.